Samsara BioCapital’s Aura Biosciences AURA Stock Holding History

Samsara BioCapital’s Portfolio AURA Stock Details AURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-584,849	Closed	-$3.61M	–	22
2025 Q3	$3.61M	Sell	584,849 -415,151	-42%	-$2.71M	0.47%	19
2025 Q2	$6.26M	Buy	+1,000,000	New	+$5.85M	1.28%	13

Other funds holding AURA

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MVM

Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Samsara BioCapital's AURA Position: Q4 2025 in Review

Samsara BioCapital sold out of Aura Biosciences (AURA) in Q4 2025, closing a stake of 584,849 shares — an estimated $3.61M sold.

Samsara BioCapital first reported a position in AURA in Q2 2025 and held it in 2 quarters. The position peaked at $6.26M in Q2 2025. 117 funds tracked by Wall St. Rank hold AURA as of Q4 2025.

Samsara BioCapital reported no remaining Aura Biosciences position as of Q4 2025 after selling out during the quarter.
Samsara BioCapital sold 584,849 Aura Biosciences shares in Q4 2025, an estimated $3.61M.
Samsara BioCapital first reported a position in Aura Biosciences in Q2 2025 and held it in 2 quarters.
Samsara BioCapital's Aura Biosciences position peaked at $6.26M in Q2 2025.
117 funds tracked by Wall St. Rank held Aura Biosciences as of Q4 2025.

Based on Samsara BioCapital's 13F filing for Q4 2025, filed 17 Feb 2026.